Array LaserLink, Manufactured by Lumenis, The Array" LaserLink" is a laser system accessory intended for use in the treatment of ocular pathology. " For the Posterior Segment, the Array" LaserLink" is indicated for use in Retinal Photocoagulation and Panretinal Photocoagulation of Vascular and Structural Abnormalities of the Retina and Choroid including: " Proliferative and Severe and Very Severe Non-Proliferative Diabetic Retinopathy " Macular Edema associated with Proliferative or Non-Proliferative Diabetic Retinopathy " Choroidal Neovascularization " Retinal Neovascularization associated with Retinal Occlusive Disease (Branch Retinal Vein Occlusion; Central Retinal Vein Occlusion) " Macular Edema associated with Branch Retinal Vein Occlusion " Retinal Tears and Detachments And Anterior Segments as follows: " Iridotomy in Closed Angle Glaucoma " Trabeculoplasty in Open Angle Glaucoma
Publicado el 8 de octubre de 2014 · Inicio del retiro: 15 de agosto de 2014
Resumen
FDA registra el retiro Z-2733-2014 de dispositivos médicos de Clase II, publicado el 8 de octubre de 2014 e iniciado el 15 de agosto de 2014. Empresa responsable: Lumenis, Inc.; Estado: Finalizado; Cantidad reportada: 16; Lote: All assembled units since product release, Part Number: GA-0006700. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Lumenis initiated a field-correction for the Array Laser Link", GA-0006700 (SN XXYYZZ) because the system may project an erroneous pattern display on the retina, which is different than the desired pattern.
Qué hacer
Voluntary: Firm initiated · Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Lumenis, Inc.
- Distribuidor
- Worldwide Distribution - USA (nationwide) and Internationally to JAPAN, CHINA, and CANADA.
- Lote
- All assembled units since product release, Part Number: GA-0006700.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDALAP-BAND AP SYSTEM AP Large with Access Port, Allergan, LAP-BAND AP SYSTEM Access Port I. Product was8 de octubre de 2014
- FDAThe Rejuvenator Chamber manufactured by Baro-Therapies, Inc. Product Usage: Indicated for relief from general8 de octubre de 2014
- FDAASSEMBLY, PATIENT SIDE CART, PS4000 used with the da Vinci Xi Surgical System. Product Usage: The Intuitive8 de octubre de 2014
- FDAVerigene BC-GP Kit (Catalog number 20-005-018); 1) 20 Verigene BC-GP Test Cartridges; are qualitative8 de octubre de 2014
- FDAReusable laparoscopic instruments are packaged as non-sterile. Cleaning and sterilization of devices must8 de octubre de 2014
- FDAVision One Laser System Model GA-0025020, Serial No: 10050, 10051, 10053. Intended for use in the treatment of18 de septiembre de 2013
Preguntas sobre este retiro
¿Array LaserLink, Manufactured by Lumenis, The Array" LaserLink" is a laser system accessory intended for use in the treatment of ocular pathology. " For the Posterior Segment, the Array" LaserLink" is indicated for use in Retinal Photocoagulation and Panretinal Photocoagulation of Vascular and Structural Abnormalities of the Retina and Choroid including: " Proliferative and Severe and Very Severe Non-Proliferative Diabetic Retinopathy " Macular Edema associated with Proliferative or Non-Proliferative Diabetic Retinopathy " Choroidal Neovascularization " Retinal Neovascularization associated with Retinal Occlusive Disease (Branch Retinal Vein Occlusion; Central Retinal Vein Occlusion) " Macular Edema associated with Branch Retinal Vein Occlusion " Retinal Tears and Detachments And Anterior Segments as follows: " Iridotomy in Closed Angle Glaucoma " Trabeculoplasty in Open Angle Glaucoma fue retirado del mercado?
Sí. FDA publicó el retiro Z-2733-2014 el 8 de octubre de 2014. Peligro reportado: Lumenis initiated a field-correction for the Array Laser Link", GA-0006700 (SN XXYYZZ) because the system may project an erroneous pattern display on the retina, which is different than the desired pattern.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Visit